Long-term Bank Loan	6 Months Ended
Jun. 30, 2018
Disclosure Text Block
Long-term Bank Loan	13. Long-term Bank Loan On September 2, 2015, BeiGene (Suzhou) entered into a loan agreement with Suzhou Industrial Park Biotech Development Co., Ltd. and China Construction Bank to borrow $18,134 at a 7% fixed annual interest rate. As of June 30, 2018, the Company has drawn down the entire $18,134, which is secured by BeiGene (Suzhou)’s equipment with a net carrying amount of $19,585 and the Company’s rights to a PRC patent on a drug candidate. The loan principal amounts of $9,067 and $9,067 are repayable on September 30, 2018 and 2019, respectively. On April 4, 2018, BeiGene Guangzhou Factory entered into a nine-year loan agreement with China Construction Bank to borrow a RMB denominated loan of $87,652 (RMB580,000) at a floating interest rate benchmarking RMB loans interest rate of financial institutions in PRC. The Company plans to draw down the entire available amount before December 31, 2019. The loan is secured by BeiGene Guangzhou Factory’s land use right with a net carrying amount of $12,132. Interest expense will be paid quarterly until the loan is fully settled. As of June 30, 2018, the Company has drawn down $42,315 in aggregate principal amount of this loan, with loan interest rate of 4.9% for the six months ended June 30, 2018, and the maturity dates are ranging from 2021 to 2027. As of June 30, 2018, the Company has unused long-term credit availability amounting to $45,337. Interest expense recognized for the three and six months ended June 30, 2018 was $421 and $752, respectively.

13. Long-term Bank Loan

On September 2, 2015, BeiGene (Suzhou) entered into a loan agreement with Suzhou Industrial Park Biotech Development Co., Ltd. and China Construction Bank to borrow $18,134 at a 7% fixed annual interest rate. As of June 30, 2018, the Company has drawn down the entire $18,134, which is secured by BeiGene (Suzhou)’s equipment with a net carrying amount of $19,585 and the Company’s rights to a PRC patent on a drug candidate. The loan principal amounts of $9,067 and $9,067 are repayable on September 30, 2018 and 2019, respectively.

On April 4, 2018, BeiGene Guangzhou Factory entered into a nine-year loan agreement with China Construction Bank to borrow a RMB denominated loan of $87,652 (RMB580,000) at a floating interest rate benchmarking RMB loans interest rate of financial institutions in PRC. The Company plans to draw down the entire available amount before December 31, 2019. The loan is secured by BeiGene Guangzhou Factory’s land use right with a net carrying amount of $12,132. Interest expense will be paid quarterly until the loan is fully settled. As of June 30, 2018, the Company has drawn down $42,315 in aggregate principal amount of this loan, with loan interest rate of 4.9% for the six months ended June 30, 2018, and the maturity dates are ranging from 2021 to 2027.

As of June 30, 2018, the Company has unused long-term credit availability amounting to $45,337. Interest expense recognized for the three and six months ended June 30, 2018 was $421 and $752, respectively.